Bayer AG (BAYGn.DE)
LEVERKUSEN, Germany - Werner Baumann, seen as heir apparent to Bayer Chief Executive Marijn Dekkers, says he will fight for the independence of Germany's largest drugmaker after the spin-off of its plastics unit.
Feb 26 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:
* Bayer news release: not intended for u.s. And uk media - bayer receives eu approval for eylea for the treatment of retinal vein occlusion
LEVERKUSEN, Germany, Feb 26 - Bayer's chief executive said the drugmaker would have to consider any attractive takeover offer for the MaterialScience unit, which Bayer plans to list on the stock exchange, but he signalled that jobs security would be taken into account.
LEVERKUSEN, Germany - Germany's largest drugmaker Bayer said it expects underlying core earnings to increase by more than 10 percent this year, banking on a boost from new drugs such as stroke prevention pill Xarelto.
* Q4 adj EBITDA, net income short of poll average (Adds research costs, expected one-offs, spin-off plans, shares)
LEVERKUSEN, Germany, Feb 26 - Germany's largest drugmaker Bayer said it expects growth in underlying core earnings in the low to mid-teens percentage range this year, as it gets a boost from new drugs such as stroke prevention pill Xarelto.
FRANKFURT, Feb 25 - Germany's Bayer named Richard Pott as supervisory board chairman of its plastics unit MaterialScience, which it plans to float on the stock market as a separate company.
FRANKFURT, Feb 25 - Germany's largest drugmaker Bayer said it would propose an annual dividend of 2.25 euros ($3) per share to investors, a tad more than the 2.23 euros expected on average by analysts.
FRANKFURT - German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.
Earnings vs. Estimates
Analyst Research Reports
Provider: Directors Deals Ltd.
Bayer - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider: Finlabo SIM Spa
Provider: Wright Reports
Provider: ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.